E71 Diffusive-infiltrative tissues

Topic

Of all the body's tissues, the brain presents the most restrictive combination of physical factors for tumor treatment, as three distinct obstacles converge there simultaneously.

The first obstacle is the blood-brain barrier—a barrier formed by the brain's blood vessels that severely limits the diffusion of drugs into brain tissue. The vast majority of cancer drugs diffuse across the blood-brain barrier far more slowly than they do through the blood vessels of any other organ, making it extremely difficult for a systemically administered drug to reach the brain tumor in sufficient quantities.

The second obstacle is the mechanical confinement imposed by the skull. Unlike a tumor in another organ—which, as it grows, can displace or compress surrounding soft tissues—a brain tumor grows within a rigid bony enclosure that cannot expand; consequently, tumor growth translates directly into increased intracranial pressure. This mechanical confinement is more extreme in the brain than in any other body tissue.

The third obstacle arises from the brain's white matter—composed of nerve fiber bundles connecting different brain regions. This structure means that tumor cell migration within the brain is not uniform in all directions but is strongly guided by these fiber bundles. Tumor cells migrate more easily along white matter tracts than in any other direction, resulting in an invasion pattern that is highly irregular and difficult to predict without knowledge of the tracts' orientation. High-grade gliomas, also known as glioblastomas, combine this diffuse invasion along the white matter with intense central hypoxia within the tumor core—that is, a lack of oxygen in the tumor's innermost regions, where growth has outpaced the supply capacity of its own blood vessels. This central hypoxia triggers a chain of two consequences: on one hand, it creates resistance to radiotherapy, as the oxygen-dependent enhancement of radiation-induced damage is lost precisely in the areas with the least oxygen; on the other hand, it favors the selection of the most aggressive tumor cell clones—those best able to survive in a low-oxygen environment.

The simulator for this type of brain tumor allows for the exploration of three distinct relationships between the brain's physical properties and tumor behavior. First, it shows how the depth of tumor invasion varies based on the migration speed of tumor cells along the white matter. Second, it demonstrates how the confinement imposed by the skull causes intracranial pressure to rise as the tumor grows. And third, it illustrates how the penetration of temozolomide—one of the most widely used chemotherapy drugs for glioblastoma—depends on the balance between its fat and water solubility: temozolomide is slightly more fat-soluble, a property that facilitates crossing the blood-brain barrier and explains why this drug reaches the brain tumor more easily than most other chemotherapy agents. It is precisely this combination of obstacles—the blood-brain barrier limiting drug delivery, the rigid confinement of the skull, anisotropic migration along white matter, and central hypoxia (which induces resistance to radiotherapy and selects for aggressive clones)—that makes a brain tumor like glioblastoma one of the most difficult to treat in all of oncology, and that justifies the need for a brain-specific simulator, distinct from that used for any other body tissue.

ID:1281